Organic Letters
Letter
(g) Hu, J.; Zhang, W.; Wang, F. Chem. Commun. 2009, 7465−7478.
(h) Landelle, G.; Panossian, A.; Pazenok, S.; Vors, J.-P.; Leroux, F. R.
Beilstein J. Org. Chem. 2013, 9, 2476−2536.
(6) Fujikawa, K.; Fujioka, Y.; Kobayashi, A.; Amii, H. Org. Lett. 2011,
13, 5560−5563.
(7) Fujiwara, Y.; Dixon, J. A.; Rodriguez, R. A.; Baxter, R. D.; Dixon, D.
D.; Collins, M. R.; Blackmond, D. G.; Baran, P. S. J. Am. Chem. Soc. 2012,
134, 1494−1497.
(8) Fier, P. S.; Hartwig, J. F. J. Am. Chem. Soc. 2012, 134, 5524−5527.
(9) Jiang, X.-L.; Chen, Z.-H.; Xu, X.-H.; Qing, F.-L. Org. Chem. Front.
2014, 1, 774−776.
(10) Prakash, G. K. S.; Ganesh, S. K.; Jones, J.-P.; Kulkarni, A.; Masood,
K.; Swabeck, J. K.; Olah, G. A. Angew. Chem., Int. Ed. 2012, 51, 12090−
12094.
Figure 3. Crystallographic structure of 19.19
In summary, we have shown that upon Lewis acid activation
TFEDMA (1,1,2,2-tetrafluoro-N,N-dimethylethan-1-amine, 1a)
reacts efficiently with alkyl or silyl enol ethers, C−H acidic
derivatives like malonitriles, and cyanoacetates to afford highly
valuable building blocks. We were also able to develop an
efficient method for the difluoroacylation of aromatics that used
either microwave irradiation or organolithium chemistry and of
heteroaromatics using conventional heating. This new method-
ology, which employs easily accessible and inexpensive starting
materials, can be scaled up and used in industrial applications.
(11) Matheis, C.; Jouvin, K.; Gooßen, L. J. Org. Lett. 2014, 16, 5984−
5987.
(12) (a) Takaoka, A.; Iwamoto, K.; Kitazume, T.; Ishikawa, N. J.
Fluorine Chem. 1979, 14, 421−428. (b) Takaoka, A.; Iwakiri, H.;
Ishikawa, N. Bull. Chem. Soc. Jpn. 1979, 52, 3377−3380. (c) Petrov, V.
A.; Swearingen, S.; Hong, W.; Chris Petersen, W. J. Fluorine Chem. 2001,
109, 25−31. (d) Takaoka, A.; Iwamoto, K.; Kitazume, T.; Ishikawa, N. J.
Fluorine Chem. 1979, 14, 421−428.
(13) Petrov, V. A.; Swearingen, S.; Hong, W.; Chris Petersen, W. J.
Fluorine Chem. 2001, 109, 25−31.
ASSOCIATED CONTENT
* Supporting Information
■
S
(14) Petrov, V. A. Adv. Org. Synth. 2006, 2, 269−290.
(15) (a) Pasternak, V. I.; Dronkina, M. I.; Kukhar, V. P.; Yagupolskii, L.
M. Zh. Org. Khim. 1978, 14, 2493−2496. (b) Wakselman, C.; Tordeux,
M. J. Chem. Soc., Chem. Commun. 1975, 956−956. (c) Grieco, L. M.;
Halliday, G. A.; Junk, C. P.; Lustig, S. R.; Marshall, W. J.; Petrov, V. A. J.
Fluorine Chem. 2011, 132, 1198−1206.
The Supporting Information is available free of charge on the
Experimental procedures and compound characterization
(16) (a) Giornal, F.; Landelle, G.; Lui, N.; Vors, J. P.; Pazenok, S.;
Leroux, F. R. Org. Process Res. Dev. 2014, 18, 1002−1009. (b) Pazenok,
S.; Giornal, F.; Landelle, G.; Lui, N.; Vors, J.-P.; Leroux, F. R. Eur. J. Org.
Chem. 2013, 2013, 4249−4253. (c) Schmitt, E.; Landelle, G.; Vors, J.-P.;
Lui, N.; Pazenok, S.; Leroux, F. R. Eur. J. Org. Chem. 2015, dx.doi.org/10.
(17) Reimann, S.; Bunescu, A.; Litschko, R.; Erfle, S.; Domke, L.;
Bendrath, F.; Abilov, Z. A.; Spannenberg, A.; Villinger, A.; Langer, P. J.
Fluorine Chem. 2012, 139, 28−45.
(18) Pashkevich, K. I.; Fomin, A. N.; Saloutin, V. I.; Bazhenov, D. V.;
Grishin, Y. K. Bull. Acad. Sci. USSR, Div. Chem. Sci. 1982, 31, 1210−
1217.
(19) CCDC 1415347 (6), 1415348 (13c), 1415349 (10), and
1415350 (19) contain the supplementary crystallographic data for this
paper. These data can be obtained free of charge from the Cambridge
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank the CNRS France (Centre National de la Recherche
Scientifique) and the University of Strasbourg and are very
grateful to Bayer S.A.S. for a grant to E.S. The French Fluorine
Network (GIS Fluor) is also acknowledged.
REFERENCES
■
(1) (a) Muller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881−
1886. (b) Jeschke, P. ChemBioChem 2004, 5, 570−589. (c) Hagmann,
W. K. J. Med. Chem. 2008, 51, 4359−4369. (d) Wang, J.; Sanchez-
Rosello, M.; Acena, J. L.; del Pozo, C.; Sorochinsky, A. E.; Fustero, S.;
Soloshonok, V. A.; Liu, H. Chem. Rev. 2014, 114, 2432−2506.
(e) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc.
Rev. 2008, 37, 320−330. (f) Fluorine In Medicinal Chemistry and
Chemical Biology; Ojima, I., Ed.; John Wiley & Sons Ltd.: New York,
2009.
(2) (a) Meanwell, N. A. J. Med. Chem. 2011, 54, 2529−2591. (b) Liang,
T.; Neumann, C. N.; Ritter, T. Angew. Chem., Int. Ed. 2013, 52, 8214−
8264.
(3) Erickson, J. A.; McLoughlin, J. I. J. Org. Chem. 1995, 60, 1626−
1631.
(4) (a) Middleton, W. J. J. Org. Chem. 1975, 40, 574−578.
(b) Markovskij, L. N.; Pashinnik, V. E.; Kirsanov, A. V. Synthesis
1973, 787−789.
(5) (a) Tomashenko, O. A.; Grushin, V. V. Chem. Rev. 2011, 111,
4475−4521. (b) Furuya, T.; Kamlet, A. S.; Ritter, T. Nature 2011, 473,
470−477. (c) Wu, X.-F.; Neumann, H.; Beller, M. Chem. - Asian J. 2012,
7, 1744−1754. (d) Jin, Z.; Hammond, G. B.; Xu, B. Aldrichimica Acta
2012, 45, 67−83. (e) Liu, X.; Xu, C.; Wang, M.; Liu, Q. Chem. Rev. 2015,
115, 683−730. (f) Liu, T.; Shen, Q. Eur. J. Org. Chem. 2012, 6679−6687.
D
Org. Lett. XXXX, XXX, XXX−XXX